Bayer AG (0P6S)
LSE
Closed
Aug 24, 2026
Day's Range
47.5352 wk Range
25.79Overview - 0P6S - Bayer AG
Key Statistics
Valuation
Enterprise Value
62.68B
P/E (Trailing)
‪19.01‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪0.99‬
Price / Book
‪1.43‬
EV / EBITDA
‪5.53‬
Profitability
Gross Margin
‪58.24%‬
Profit Margin
‪-6.17%‬
Operating Margin
‪16.37%‬
Return on Assets
‪4.04%‬
Return on Equity
‪-8.17%‬
Ownership
Shares Outstanding
982.42M
Float
982.31M
Held by Insiders
‪0.02%‬
Held by Institutions
‪49.03%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪46.85‬
200-Day Avg
‪40.68‬
Market Cap - 0P6S - Bayer AG
Peers - 0P6S - Bayer AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0P6SLSEBayer AG47.05BMarket Cap+41.21%52-week change19.01P/E (Trailing)‪-6.17%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.02%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0P6S - Bayer AG
About
Bayer AG is a global life science company operating in healthcare and nutrition sectors. It functions through three primary segments: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals segment develops prescription products for cardiology and women’s health, specialty therapeutics in oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
